Consequently, nanoSTING‐vax significantly enhanced MHC‐I antigen presentation, boosted DC maturation, and triggered robust antigen‐specific CD8+ T‐cell priming, leading to effective tumor suppression in multiple murine models.[100a]. Here, CD8A is linked to neoplasm.